Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
Stem wins New York battery storage services agreement with Bluesphere
Stem agreed to provide revenue modeling, market analysis and operational intelligence for Bluesphere Ventures’ standalone battery projects participating in New York’s VDER program within Con Edison territory. The engagement uses real operating data, models multiple tariff and cycling scenarios, and includes a bespoke Local Law 97 optimization capability to identify additional revenue streams. Management says the work can reduce the gap between projected and realized project performance, while UBS recently trimmed its Stem price target to $10.50 from $12 and kept a Neutral rating. » Altro su finance.yahoo.com
Stem reports Q4 loss per share of $1.88 on declining quarterly revenue
Stem reported a loss per share of $1.88 for the quarter ended December 31, 2025 (prior year: -$6.00) and revenue of $47.2 million, down from $55.8 million in the year‑ago quarter (−15.5%). For the full year, loss per share was $9.18 versus -$105.80 in the prior year, while annual revenue rose to $156.27 million (+8.09%). » Altro su finanzen.net
Stem consolidates product and brand portfolio into PowerTrack Suite
Stem is combining its technology and brand portfolio under the new PowerTrack Suite, including the PowerTrack EMS for controlling battery systems and the PowerTrack Optimizer (formerly Athena). The company is also developing PowerTrack Sage, an AI-powered workflow solution based on large language models. Stem most recently reported revenue of $156 million (last 12 months) and reported Q2 2025 revenue growth of 13% to $38.4 million, but faces a high cash burn rate and significant debt. Analysts raised price targets but maintained a "neutral" rating; the consolidation will be presented at RE+ 2025. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | 2023 | |
|---|---|---|
| Ricavi | 0 | 100,00% |
| Utile lordo | 0 | 100,00% |
| Utile netto | -17,96 Mln | 1,42% |
| EBITDA | -3,69 Mln | 1198,81% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 57,66 € |
Numero di azioni | 6,7 Mln |
Massimo/minimo a 52 settimane | 0,0262 € - 0,0000086 € |
| Dividendi | No |
Beta | 0,91 |
Rapporto P/E | 0,00 |
Rapporto PEG | 0,00 |
Rapporto P/B | 0,00 |
Rapporto P/S | 0,00 |
Profilo aziendale
Stem Holdings, Inc. ist ein vertikal integriertes Unternehmen für Cannabisprodukte und -technologie. Es beschäftigt sich mit der Produktion, dem Vertrieb und dem Verkauf von Cannabis und mit Cannabis versetzten Produkten. Zu den Marken des Unternehmens gehören TJ's Gardens, TravisxJames und Yerba Buena-Blüten und -Extrakte, Cannavore-Süßwaren, Doseology, eine CBD-Marke für den Massenmarkt, und die Delivery-as-a-Service-Marken der E-Commerce-Plattformen Budee und Ganjarunner. Zum 30. September 2021 besaß es Eigentumsanteile an 29 staatlich erteilten Cannabislizenzen, darunter 9 Lizenzen für den Cannabisanbau, 3 Lizenzen für die Cannabisverarbeitung, 2 Lizenzen für den Cannabisgroßhandel, 3 Lizenzen für die Hanfproduktion, 7 Lizenzen für Cannabisabgabestellen und 5 Lizenzen für medizinische Einzelhändler für Erwachsene. Das Unternehmen wurde im Jahr 2016 gegründet und hat seinen Hauptsitz in Boca Raton, Florida.
| Nome | STEM HOLDINGS INC.DL-,001 Aktie |
| CEO | Matthew J. Cohen |
| Sede centrale | Boca Raton,
fl Stati Uniti |
| Sito web | |
| Settore | Beni di prima necessità |
| Industria | Prodotti per la cura della persona |
| Quotazione in borsa | 08/01/2021 |
| Dipendenti | 75 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Pnk | STMH |
Scopri gli asset
Gli azionisti di STEM HOLDINGS INC.DL-,001 Aktie investono anche nei seguenti asset









